Informations sur le produit
- 4-[4-[[5-(4,5-Dimethyl-2-nitrophenyl)-2-furanyl]methylene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-benzoic acid
- C 646
Applications C646 is an inhibitor for histone acetyltransferase p300 and may be a potential candidate for treating AML1-ETO (AE) positive acute myeloid leukemia (AML). It is shown that C646 inhibited cellular proliferation, reduced colony formation, evoked partial cell cycle arrest in the G1 phase, and induced apoptosis in AE-positive AML cell lines and primary blasts isolated from leukemic mice and AML patients.
References Gao, X., et al.: Zhang, X., et al.: PLoS One, 8, e55481 (2013); Zhonghua Shiyan Waike Zazhi, 30, 1177 (2013); Bowers, E.M., et al.: Chem. Biol., 17, 471 (2010)